{"id":"W2101968968","doi":"10.2147/dddt.s70299","title":"Differential benefit risk assessment of DOACs in the treatment of venous thromboembolism: focus on dabigatran","year":2015,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Dabigatran; Medicine; Apixaban; Rivaroxaban; Edoxaban; Intensive care medicine; Direct thrombin inhibitor; Dosing; Warfarin; Atrial fibrillation; Pharmacology; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006475184,0.000766391,0.004099574,0.0004420611,0.0001230129,0.00003431131,0.0002780931,0.0002339194,0.00008823536],"category_scores_gemma":[0.000008091092,0.0004475875,0.0003955333,0.0003548444,0.0001384474,0.00004088983,0.00004766598,0.0002787578,0.000008778123],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003750995,"about_ca_system_score_gemma":0.000714435,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000172057,"about_ca_topic_score_gemma":0.00004969848,"domain_scores_codex":[0.9967067,0.0003160055,0.001239637,0.0006042194,0.0006871328,0.000446274],"domain_scores_gemma":[0.9979522,0.0003040565,0.0007859336,0.0006756756,0.0001176986,0.0001644517],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00009269812,0.004961548,0.0001355343,0.001453177,0.002000756,0.0000167655,0.003569844,0.000006776641,0.000004927839,0.0004317836,0.0002695556,0.9870566],"study_design_scores_gemma":[0.004371556,0.002417095,0.005726201,0.005619762,0.0020765,0.00001270218,0.000126872,0.000008014955,0.0004514251,0.0006736727,0.9778627,0.000653474],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.02706645,0.9670598,0.0001826452,0.00008119125,0.0003259061,0.004556987,0.0000383588,0.00003292865,0.0006557169],"genre_scores_gemma":[0.007069085,0.9900883,0.001657568,0.00002909983,0.0001280509,0.0005986957,0.0001383663,0.00008939793,0.0002014616],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9864032,"threshold_uncertainty_score":0.9997976,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09982856678948611,"score_gpt":0.3585364966659736,"score_spread":0.2587079298764875,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}